$Finch Therapeutics Group, Inc.(FNCH)$$Myovant Sciences Ltd.(MYOV)$MYOV Target of acquisition by Sumi who is facing patent cliff and already bought out 4 others “vant”companies. Besides, the fundamentals are strong here… 2 blockbuster drugs approved and commercialised by $Pfizer(PFE)$ with tiered payment for 4.2billion.. MYOV also holding cash in excess of 600millions with a market capital of $1.3billion. Definitelya good buyout at $30 minimum. Let’s take this opportunity to stand up against the giants who has been manupulating this and robbing the common investors like us.
Enterprise Value vs EBITA is 20x stronger than last quarter when the price is ard $30
精彩评论